Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9402) , 18-22
- https://doi.org/10.1016/s0140-6736(03)15163-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of Dihydroartemisinin‐Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum MalariaClinical Infectious Diseases, 2002
- Combination Therapy for MalariaDrugs, 2002
- Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitroTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquineTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.The American Journal of Tropical Medicine and Hygiene, 1999
- Averting a malaria disasterThe Lancet, 1999
- Invited review Bisquinoline antimalarials: their role in malaria chemotherapyInternational Journal for Parasitology, 1999
- Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.The American Journal of Tropical Medicine and Hygiene, 1999
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998
- An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet NamTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994